Crystallization (Comment) | Organism |
---|---|
purified bZiPro (C143S)-inhibitor 5-amino-1-((4-methoxyphenyl)sulfonyl)-1H-pyrazol-3-yl benzoate complex and bZiPro (C143S)-Ac-Lys-Arg complex, X-ray diffraction structure determination and analysis at 1.90 A and 1.51 A resolution, respectively | Zika virus |
Protein Variants | Comment | Organism |
---|---|---|
C143S | site-directed mutagenesis, the NS2B mutant cannot form the disulfide bond between C143 residues of neighboring NS3 | Zika virus |
Inhibitors | Comment | Organism | Structure |
---|---|---|---|
5-amino-1-((4-methoxyphenyl)sulfonyl)-1H-pyrazol-3-ol | - |
Zika virus | |
5-amino-1-((4-methoxyphenyl)sulfonyl)-1H-pyrazol-3-yl benzoate | the benzoyl moiety of the inhibitor forms a covalent bond with the side chain of S135. Structure and dynamics of bZiPro-inhibitor complex in solution | Zika virus | |
additional information | structural insights into the inhibition of Zika virus NS2B-NS3 protease by a small-molecule inhibitor, structure and dynamics, overview. 5-amino-1-((4-methoxyphenyl)sulfonyl)-1H-pyrazol-3-yl benzoate stabilizes the closed conformation of ZIKV protease. Upon hydrolysis in situ into two fragments, the benzoyl group of the inhibitor forms a covalent bond with the side chain of catalytic residue S135, whereas the second fragment exhibits no obvious molecular interactions with the protease, detailed mechanism of action of a covalent inhibitor. Unique adduct of the benzoyl moiety to residue S135 | Zika virus |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Zika virus | - |
- |
- |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
benzoyl-Nle-Lys-Arg-Arg-7-amido-4-methylcoumarin + H2O | - |
Zika virus | benzoyl-Nle-Lys-Arg-Arg + 7-amino-4-methylcoumarin | - |
? |
Subunits | Comment | Organism |
---|---|---|
dimer | Zika protease is able to form a dimer, and a disulfide bond between C143 residues of neighboring NS3 in the crystal is observed | Zika virus |
Synonyms | Comment | Organism |
---|---|---|
NS2B-NS3 protease | - |
Zika virus |
Zika protease | - |
Zika virus |
Zika virus NS2B-NS3 protease | - |
Zika virus |
Cofactor | Comment | Organism | Structure |
---|---|---|---|
NS2B cofactor | the viral protease is a two-component serine protease formed by the N-terminal part of NS3 and the cofactor region of NS2B, a membrane protein essential for the membrane location of NS3. The NS2B mutant C143S cannot form the disulfide bond between C143 residues of neighboring NS3 | Zika virus |
IC50 Value | IC50 Value Maximum | Comment | Organism | Inhibitor | Structure |
---|---|---|---|---|---|
0.0015 | - |
20xa0mM Tris pH 8.5, 10% glycerol, 0.01% Triton X-100, 37°C | Zika virus | 5-amino-1-((4-methoxyphenyl)sulfonyl)-1H-pyrazol-3-yl benzoate |
General Information | Comment | Organism |
---|---|---|
additional information | the viral protease is a two-component serine protease formed by the N-terminal part of NS3 and the cofactor region of NS2B, a membrane protein essential for the membrane location of NS3 | Zika virus |